View Clinical Trial (Medical Research Study)


A Study of MK7009 in Patients With Chronic Hepatitis C Infection After Participation in Other MK7009 Studies - NCT00943761-28203(Clinical Trial 421294)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Charlotte
State:  
NC
Zip Code: 28203
Conditions: Chronic Hepatitis C Infection
Purpose: This study will provide MK7009 600 mg twice daily in combination with pegylated interferon and ribavirin to patients with chronic hepatitis C virus (HCV) infection who did not achieve viral eradication while participating in a prior MK7009 clinical trial.
Study summary:
Criteria: Inclusion Criteria: - Patient has participated in a prior MK7009 clinical trial - Patient agrees to use acceptable birth control method during treatment Exclusion Criteria: - Patient discontinued MK7009 and/or peg-IFN and/or RBV in the prior study - Patient completed the prior study more than 6 months ago - Patient received any therapy for HCV after participating in the prior study
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: February 17, 2010
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.